Financials Alteco Medical AB

Equities

ALTE

SE0005620408

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
0.12 SEK -6.98% Intraday chart for Alteco Medical AB +9.09% -65.71%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 33.3 32.3 42.4 47.29 52.78 24.08
Enterprise Value (EV) 1 32.78 23.34 39.89 41.74 51.82 26.03
P/E ratio -2.59 x -3.42 x -5.27 x -6.73 x -13.7 x -4.13 x
Yield - - - - - -
Capitalization / Revenue 7.27 x 4.18 x 7.4 x 6.02 x 6.39 x 2.93 x
EV / Revenue 7.16 x 3.02 x 6.96 x 5.31 x 6.28 x 3.17 x
EV / EBITDA -2.56 x -2.53 x -5.12 x -7.18 x -15.2 x -4.9 x
EV / FCF -1.28 x 2.04 x -9.86 x -7.38 x -16.6 x -4.16 x
FCF Yield -78% 49% -10.1% -13.5% -6.03% -24%
Price to Book 1.42 x 2.49 x 7.67 x 4.91 x 9.16 x 4.43 x
Nbr of stocks (in thousands) 27,296 45,493 46,188 50,038 57,188 57,188
Reference price 2 1.220 0.7100 0.9180 0.9450 0.9230 0.4210
Announcement Date 4/30/18 4/29/19 4/23/20 4/20/21 5/4/22 5/10/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 4.58 7.729 5.733 7.861 8.259 8.221
EBITDA 1 -12.79 -9.211 -7.788 -5.809 -3.405 -5.313
EBIT 1 -12.97 -9.381 -8.031 -6.12 -3.837 -5.755
Operating Margin -283.22% -121.38% -140.09% -77.85% -46.46% -70%
Earnings before Tax (EBT) 1 -12.83 -9.434 -8.05 -7.029 -3.861 -5.833
Net income 1 -12.83 -9.434 -8.05 -7.029 -3.861 -5.833
Net margin -280.22% -122.07% -140.41% -89.42% -46.75% -70.96%
EPS 2 -0.4701 -0.2074 -0.1743 -0.1405 -0.0675 -0.1020
Free Cash Flow 1 -25.58 11.43 -4.046 -5.653 -3.123 -6.254
FCF margin -558.52% 147.92% -70.57% -71.91% -37.81% -76.07%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/18 4/29/19 4/23/20 4/20/21 5/4/22 5/10/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - 1.95
Net Cash position 1 0.52 8.96 2.51 5.55 0.96 -
Leverage (Debt/EBITDA) - - - - - -0.3678 x
Free Cash Flow 1 -25.6 11.4 -4.05 -5.65 -3.12 -6.25
ROE (net income / shareholders' equity) -61.7% -51.8% -87.1% -92.8% -50.2% -104%
ROA (Net income/ Total Assets) -35.5% -28.4% -45% -37.1% -22.3% -38%
Assets 1 36.14 33.17 17.88 18.95 17.28 15.33
Book Value Per Share 2 0.8600 0.2800 0.1200 0.1900 0.1000 0.0900
Cash Flow per Share 2 0.0200 0.2000 0.0500 0.1500 0.0200 0.0100
Capex - 0.37 0.32 0.54 0.12 -
Capex / Sales - 4.78% 5.51% 6.92% 1.46% -
Announcement Date 4/30/18 4/29/19 4/23/20 4/20/21 5/4/22 5/10/23
1SEK in Million2SEK
Estimates
  1. Stock Market
  2. Equities
  3. ALTE Stock
  4. Financials Alteco Medical AB